Emla and Quit smoking - a phase IV clinical study of FDA data
We study 91,944 people who take Emla or have Quit smoking. No report of Quit smoking is found in people who take Emla.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Emla?
Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 4,653 Emla users for its effectiveness, alternative drugs and more.
What is Quit Smoking?
Quit smoking is found to be associated with 1,290 drugs and 902 conditions by eHealthMe.
Do you take Emla and have Quit smoking?Check whether Quit smoking is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Quit smoking and when was it recovered:
Expand to all the drugs that have ingredients of lidocaine; prilocaine:
Alternative drugs to, pros and cons of Emla:
- Emla (4,653 reports)
Quit smoking treatments and more:
- Quit smoking (87,291 reports)
COVID vaccines that are related to Quit smoking:
- Quit smoking in Moderna COVID Vaccine
- Quit smoking in Pfizer BioNTech Covid Vaccine
- Quit smoking in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Quit smoking:
All the conditions that are associated with Quit smoking:
How the study uses the data?
The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxcarbazepine and Yawning - a second ago
- Camptosar and Warfarin Sodium drug interaction - a second ago
- Zytiga and Hypertrophy - 2 seconds ago
- Clexane and Tofacitinib Citrate drug interaction - 6 seconds ago
- Methotrexate and Miller Fisher Syndrome - 15 seconds ago
- Oxycontin and Emtricitabine drug interaction - 16 seconds ago
- Peg-Intron and Infected Cyst - 21 seconds ago
- Regular Insulin and Drooling - 25 seconds ago
- Suboxone and Insulin drug interaction - 30 seconds ago
- Gemcitabine and Thyroid Diseases - 31 seconds ago